Pfizer says FDA OKs updated infection vaccine

February 24, 2010 By MATTHEW PERRONE , AP Business Writer

(AP) -- Pfizer says the Food and Drug Administration has approved an updated version of its best-selling infection vaccine for children.

Prevnar 13 is intended to reduce the risk of infection by 13 varieties of pneumococcal disease, which causes ear infections, meningitis and . The new vaccine adds protection against six additional varieties of bacterial infection compared with the current vaccine.

The vaccine, developed by Wyeth, is the first product to win FDA approval since Pfizer acquired Wyeth last year.

With sales of $2.7 billion in 2008, Prevnar was considered a key product in Pfizer's decision to purchase Wyeth for $68 billion.

shares

Related Stories

Recommended for you

Universal flu vaccine designed by scientists

September 30, 2016

An international team of scientists have designed a new generation of universal flu vaccines to protect against future global pandemics that could kill millions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.